These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. After fen-phen. Cowley G; Springen K Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270 [No Abstract] [Full Text] [Related]
23. A dangerous duo? A combination of common diet drugs (fen-phen) may lead to heart valve disease. Boughner DR CMAJ; 1997 Sep; 157(6):705-6. PubMed ID: 9307558 [No Abstract] [Full Text] [Related]
24. Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment. Cannistra LB; Cannistra AJ N Engl J Med; 1998 Sep; 339(11):771. PubMed ID: 9742026 [No Abstract] [Full Text] [Related]
35. The age-adjusted mortality rate from primary pulmonary hypertension, in age range 20 to 54 years, did not increase during the years of peak "phen/fen" use. Rothman RB Chest; 2000 Nov; 118(5):1516-7. PubMed ID: 11083718 [No Abstract] [Full Text] [Related]
36. Do these doctors give medicine a black eye? Rice B Med Econ; 2003 Dec; 80(24):58-62, 65, 69. PubMed ID: 14733056 [No Abstract] [Full Text] [Related]
37. Obesity and an abnormal ECG. Hancock EW Hosp Pract (1995); 1997 Sep; 32(9):19-20. PubMed ID: 9307592 [No Abstract] [Full Text] [Related]
39. [Drug-clinics. The hue and cry over central appetite suppressants!]. Scheen AJ Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348 [No Abstract] [Full Text] [Related]
40. Anorectic therapy and valvular heart disease: a reappraisal. Silvestry FE; St John Sutton M Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]